METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial–mesenchymal transition

Jianting Man, Zongyuan Zhang, Tianxing Cui, Tiefeng Shi · 2025

Read METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial–mesenchymal transition by Jianting Man, Zongyuan Zhang, Tianxing Cui, Tiefeng Shi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12780034.txt.

Description

Jianting Man and co-authors study a gene that slows a common thyroid cancer in a 2025 paper. The cancer is the prevalent kind of endocrine tumor, and the gene, TACSTD2, is involved in the growth of many cancers. Its role in this thyroid cancer was unclear, so the team ran loss and gain tests in cells and in mice.

Removing the gene sped cell growth, movement, and invasion, while adding it back did the reverse, and tumors grew less in mice without it. The gene proved to be a target of a chemical mark on RNA, placed by an enzyme that cuts its stability. Restoring the gene partly undid the mark effect. Pathways for immune signals and cell shape change were involved.

Catalog record

CREATORJianting Man, Zongyuan Zhang, Tianxing Cui, Tiefeng Shi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12780034

Browse the full library · About the Tower of Babel